Back to User profile » Dr Zhihui Wang
Papers published by Dr Zhihui Wang:
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
CD47 Overexpression Is Associated with Epstein–Barr Virus Infection and Poor Prognosis in Patients with Nasopharyngeal Carcinoma
Wang ZH, Pei XF, Zhu ZQ, Lin Z, Mao YY, Xu XL, Luo YL, Zhang L, Peng PJ
OncoTargets and Therapy 2020, 13:3325-3334
Published Date: 21 April 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Efficacy and safety of pemetrexed and nedaplatin followed by pemetrexed maintenance therapy in advanced lung adenocarcinoma
Lin Z, Lv WZ, Wang SY, Zou JL, Con YY, Wang ZH, Xiao M, Peng PJ
Cancer Management and Research 2017, 9:671-677
Published Date: 20 November 2017
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Everolimus enhances cellular cytotoxicity of lapatinib via the eukaryotic elongation factor-2 kinase pathway in nasopharyngeal carcinoma cells
Liu L, Wang ZH, Han J, Tang C, Chen N, Lin Z, Peng PJ
OncoTargets and Therapy 2016, 9:6195-6201
Published Date: 11 October 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Phase II trial of docetaxel combined with nedaplatin for patients with recurrent and metastatic nasopharyngeal carcinoma
Peng PJ, Lv BJ, Tang C, Liao H, Lin Z, Liu YM, Wang ZH, Wang SY, Cheng ZB
Drug Design, Development and Therapy 2015, 9:6401-6405
Published Date: 10 December 2015